180 related articles for article (PubMed ID: 31479579)
1. Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome.
Scambi C; Ugolini S; Tonello M; Bortolami O; De Franceschi L; Castagna A; Lotti V; Corbella M; Raffaelli R; Caramaschi P; Mattia E; Biasi D; Ruffatti A
Am J Reprod Immunol; 2019 Dec; 82(6):e13185. PubMed ID: 31479579
[TBL] [Abstract][Full Text] [Related]
2. Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome.
Bertolaccini ML; Contento G; Lennen R; Sanna G; Blower PJ; Ma MT; Sunassee K; Girardi G
J Autoimmun; 2016 Dec; 75():30-38. PubMed ID: 27160365
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid antibody carriers and patients with quiescent antiphospholipid syndrome show persistent subclinical complement activation.
Zen M; Tonello M; Favaro M; Del Ross T; Calligaro A; Giollo A; Vesentini F; Gennaio IA; Arru F; Ruffatti A; Doria A
Rheumatology (Oxford); 2024 May; 63(6):1733-1738. PubMed ID: 37774001
[TBL] [Abstract][Full Text] [Related]
4. Expression of complement regulatory proteins: CD46, CD55, and CD59 and response to rituximab in patients with CD20+ non-Hodgkin's lymphoma.
Dzietczenia J; Wróbel T; Mazur G; Poreba R; Jaźwiec B; Kuliczkowski K
Med Oncol; 2010 Sep; 27(3):743-6. PubMed ID: 19662541
[TBL] [Abstract][Full Text] [Related]
5. Classical complement activation as a footprint for murine and human antiphospholipid antibody-induced fetal loss.
Cohen D; Buurma A; Goemaere NN; Girardi G; le Cessie S; Scherjon S; Bloemenkamp KW; de Heer E; Bruijn JA; Bajema IM
J Pathol; 2011 Dec; 225(4):502-11. PubMed ID: 21688269
[TBL] [Abstract][Full Text] [Related]
6. High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets.
Ruffatti A; Tonello M; Calligaro A; Del Ross T; Favaro M; Zen M; Carletto A; Lotti V; Bertoldo E; Tedesco F; Hoxha A; Biasi D
Clin Exp Rheumatol; 2022 Nov; 40(11):2088-2096. PubMed ID: 35238757
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro.
Geis N; Zell S; Rutz R; Li W; Giese T; Mamidi S; Schultz S; Kirschfink M
Curr Cancer Drug Targets; 2010 Dec; 10(8):922-31. PubMed ID: 20879979
[TBL] [Abstract][Full Text] [Related]
9. Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS).
Grosso G; Vikerfors A; Woodhams B; Adam M; Bremme K; Holmström M; Ågren A; Eelde A; Bruzelius M; Svenungsson E; Antovic A
Thromb Res; 2017 Oct; 158():168-173. PubMed ID: 28669410
[TBL] [Abstract][Full Text] [Related]
10. Relative Contribution of Cellular Complement Inhibitors CD59, CD46, and CD55 to Parainfluenza Virus 5 Inhibition of Complement-Mediated Neutralization.
Li Y; Parks GD
Viruses; 2018 Apr; 10(5):. PubMed ID: 29693588
[TBL] [Abstract][Full Text] [Related]
11. Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome.
Breen KA; Seed P; Parmar K; Moore GW; Stuart-Smith SE; Hunt BJ
Thromb Haemost; 2012 Mar; 107(3):423-9. PubMed ID: 22234447
[TBL] [Abstract][Full Text] [Related]
12. Absence of Distinct Immunohistochemical Distribution of Annexin A5, C3b, C4d, and C5b-9 in Placentas From Patients With Antiphospholipid Antibodies, Preeclampsia, and Systemic Lupus Erythematosus.
Matrai CE; Rand JH; Baergen RN
Pediatr Dev Pathol; 2019 Oct; 22(5):431-439. PubMed ID: 30922166
[TBL] [Abstract][Full Text] [Related]
13. A novel 2-stage approach that detects complement activation in patients with antiphospholipid antibody syndrome.
Rand JH; Wu XX; Wolgast LR; Lei V; Conway EM
Thromb Res; 2017 Aug; 156():119-125. PubMed ID: 28628799
[TBL] [Abstract][Full Text] [Related]
14. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome.
Simchen MJ; Dulitzki M; Rofe G; Shani H; Langevitz P; Schiff E; Pauzner R
Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1428-33. PubMed ID: 21729009
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD59, a regulator of the membrane attack complex of complement, on human skeletal muscle fibers.
Navenot JM; Villanova M; Lucas-Héron B; Malandrini A; Blanchard D; Louboutin JP
Muscle Nerve; 1997 Jan; 20(1):92-6. PubMed ID: 8995588
[TBL] [Abstract][Full Text] [Related]
16. Mitigating placental injuries through up-regulating DAF in experimental APS mice: new mechanism of progesterone.
Zhang Y; Jin S
Clin Exp Immunol; 2019 Sep; 197(3):376-386. PubMed ID: 31091357
[TBL] [Abstract][Full Text] [Related]
17. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
Koski CL; Estep AE; Sawant-Mane S; Shin ML; Highbarger L; Hansch GM
J Neurochem; 1996 Jan; 66(1):303-12. PubMed ID: 8522968
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy.
Mayer-Pickel K; Eberhard K; Lang U; Cervar-Zivkovic M
Clin Rev Allergy Immunol; 2017 Aug; 53(1):54-67. PubMed ID: 27395067
[TBL] [Abstract][Full Text] [Related]
19. Soluble HLA-DR and soluble CD95 ligand levels in pregnant women with antiphospholipid syndromes.
Rebmann V; Ronin-Walknowska E; Sipak-Szmigiel O; Miklaszewicz A; Czajkowska E; Grosse-Wilde H
Tissue Antigens; 2003 Dec; 62(6):536-41. PubMed ID: 14617037
[TBL] [Abstract][Full Text] [Related]
20. Complement activation and pregnancy failure.
Tincani A; Cavazzana I; Ziglioli T; Lojacono A; De Angelis V; Meroni P
Clin Rev Allergy Immunol; 2010 Dec; 39(3):153-9. PubMed ID: 19936969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
